Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia
NAGIOS: RODERIC FUNCIONANDO

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

DSpace Repository

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

Show simple item record

dc.contributor.author Gil Guillén, Vicente F. es_ES
dc.contributor.author Orozco Beltrán, Domingo es_ES
dc.contributor.author Redón i Más, Josep es_ES
dc.contributor.author Pita Fernandez, Salvador es_ES
dc.contributor.author Navarro-Pérez, Jorge es_ES
dc.contributor.author Pallarés, Vicente es_ES
dc.contributor.author Valls, Francisco es_ES
dc.contributor.author Fluixa, Carlos es_ES
dc.contributor.author Fernández, Antonio es_ES
dc.contributor.author Martín Moreno, José María es_ES
dc.contributor.author Pascual-de-la-Torre, Manuel es_ES
dc.contributor.author Trillo, Jose L. es_ES
dc.contributor.author Durazo Arvizu, Ramón es_ES
dc.contributor.author Cooper, Richard es_ES
dc.contributor.author Hermenegildo, Marta es_ES
dc.contributor.author Rosado, Luis es_ES
dc.date.accessioned 2015-06-29T10:34:10Z
dc.date.available 2015-06-29T10:34:10Z
dc.date.issued 2010 es_ES
dc.identifier.uri http://hdl.handle.net/10550/44804
dc.description.abstract BackgroundThe Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study.Methods/DesignA cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System (primary and secondary care). The system covers about 95% of population (near 5 million people). The system is linked with database of mortality register, hospital withdrawals, prescriptions and assurance databases in which each individual have a unique identification number. Diagnoses in clinical practice are always registered based on IDC-9. Occurrence of CV disease was the main outcomes of interest. Risk survival analysis methods will be applied to estimate the cumulative incidence of developing CV events over time.DiscussionThe Escarval-Risk study will provide information to validate different cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia from a low risk Mediterranean Region, the Valencia Community. es_ES
dc.source BMC Public Health Vol. 10 pp. 717-717 es_ES
dc.title Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.identifier.doi 10.1186/1471-2458-10-717 es_ES
dc.identifier.idgrec 064993 es_ES
dc.identifier.idgrec 066808

View       (526.3Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics